Fred Aslan SEC EDGAR Filings (CIK 0001909362)

SEC EDGAR filings, ownership reports, and insider transactions for Fred Aslan.

Business address
C/O Artiva Biotherapeutics, Inc., 4747 Executive Drive, Suite 1150, San Diego, CA, 92121
Top holdings (ownership)
ARTV
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Fred Aslan has filed 13 SEC EDGAR filings since 18 Jul 2024

Latest Filings

Recent SEC filings for Fred Aslan including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 18 Feb 2026 15 Feb 2026 001-42179
4 Open 4 document View SEC filing for 4 4 15 Dec 2025 15 Dec 2025 001-42179
144 Open 144 document View SEC filing for 144 15 Dec 2025
4 Open 4 document View SEC filing for 4 4 12 Dec 2025 12 Dec 2025 001-42179
4 Open 4 document View SEC filing for 4 4 17 Nov 2025 15 Nov 2025 001-42179
144 Open 144 document View SEC filing for 144 17 Nov 2025
4 Open 4 document View SEC filing for 4 17 Oct 2025 17 Oct 2025 001-42179
144 Open 144 document View SEC filing for 144 17 Oct 2025
4 Open 4 document View SEC filing for 4 18 Aug 2025 15 May 2025 001-42179
144 Open 144 document View SEC filing for 144 15 Aug 2025
4 Open 4 document View SEC filing for 4 07 Mar 2025 05 Mar 2025 001-42179
4 Open 4 document View SEC filing for 4 22 Jul 2024 18 Jul 2024 001-42179
3 Open 3 document View SEC filing for 3 18 Jul 2024 18 Jul 2024 001-42179

About this filer

Fred Aslan files with the SEC under CIK 0001909362. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages